The univariate analysis revealed that KIF2A-high correlated significantly with a poor OS (hazard ratio [HR]: 0.334; 95% confidence interval [CI]: 0.246–0.453; p < 0.001) and with previously reported prognostic markers, including differentiation (HR: 1.38; 95% CI: 1.146–1.661; p = 0.001), TNM stage (HR: 1.563; 95% CI: 1.444–1.691; p < 0.001), lymph node metastasis (HR: 1.648; 95% CI: 1.483–1.833; p < 0.001), and distant metastasis (HR: 3.167; 95% CI: 2.518–4.646; p < 0.001) (Table 3). The gene discussed is KIF2A; the disease is metastatic malignant neoplasm in the lymph nodes.